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THE DECISION-TREE MODEL IN 
PHARMACOECONOMIC ANALYSIS OF SHORT-TERM 
ANTIBIOTICS VERSUS STANDARD COURSE OF ORAL 
PENICILLIN IN TREATING CHILDREN WITH ACUTE 
STREPTOCOCCAL PHARYNGITIS
Alona Masheiko, 
Olga Makarenko,
Doctor of Medical Sciences, Associate Professor,
SE «Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine»
Annotation. This article presents the results of the cost-effectiveness analysis of using 
short-term treatment with azithromycin, clarithromycin, cefuroxime and amoxicillin/clavulanate 
compared to standard 10-day course of oral penicillin in treating children with acute streptococcal 
pharyngitis. It was found, that the cost-effectiveness ratio (CER) of 5-day course of clarithromycin 
was 50% lower than CER of standard treatment with oral penicillin.
Keywords: pharyngitis/drug therapy, pharyngitis/economics, Streptococcus pyogenes, child.
Acute streptococcal pharyngitis is a common disease of the upper respiratory tract 
[1], late diagnosis and inadequate treatment of which may cause the development of 
early suppurative (peritonsillar abscess, cervical lymphadenitis, acute otitis media, 
mastoiditis, acute sinusitis) and late non-suppurative (acute rheumatic fever, acute 
poststreptococcal glomerulonephritis, rheumatic heart disease and poststreptococcal 
reactive arthritis) complications [2].
The basis for the treatment of acute streptococcal pharyngitis has been recognized 
to be antibacterial chemotherapy for eradication of the causative agent. It leads to 
reducing the severity and duration of clinical manifestations of infection, prevents 
poststreptococcal complications and infection spreading [3].
“Gold-standard treatment” of acute streptococcal pharyngitis is penicillin due to its 
clinical effectiveness, narrow bacteriological spectrum, relative safety and low cost [4].
It is known that Streptococcus pyogenes is completely sensitive to penicillin. 
Resistance has not developed to penicillin [2]. 
However, data on bacteriological treatment failure to penicillin (Streptococcus 
pyogenes eradication is asent) appeared in the literature. It can be caused by poor patient 
adherence to medication, synthesis of β-lactamase concomitant pharynx microflora, 
poor penetration of antibiotics into the focus of infection, etc [5].
It was found, that 10-day course of treatment is not completed by not all patients. 
Most patients consider taking antibiotics after the first 2-3 days against the backdrop 
of improving health and the absence of symptoms unnecessary [6]. According to this 
reason the scientific priority remains the research for antibiotics capable for the shorter 
term to ensure the same results as the 10-day course of oral penicillin.
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 The limited financial resources for health care are another important reason that 
motivates researchers to seek rational approaches to antimicrobial therapy. Based on the 
saving state budget and personal funds, essential part of patient pharmaceutical provision 
is pharmacoeconomic analysis that compares costs and outcomes between the standard 
and alternative treatment scheme.
Objective:  to compare cost-effectiveness evaluation of using short duration 
treatment with azithromycin, clarithromycin and oral cefuroxime with standard 10-day 
course of oral penicillin in treating children with acute streptococcal pharyngitis.
Materials and methods. The object of pharmacoeconomic assessment was results 
of comparative prospective randomized controlled multicenter clinical trials comparing 
short duration oral antibiotics azithromycin (20 mg/kg), clarithromycin (7.5 mg/kg) and 
cefuroxime (10 mg/kg) to standard 10-day duration oral penicillin in children with acute 
streptococcal pharyngitis [7, 8, 9]. 
The decision-tree model was used to select the most effective and the least 
costly treatment approach. The essence of this method is to compare the likelihood 
of Streptococcus pyogenes eradication and economic costs for each of the compared 
approaches. Add-in PrecisionTree for Microsoft Excel, which has been developed by 
Palisade Corporation, was used to build the decision-tree model.
The effectiveness of treatment was estimated based on the criteria for achieving 
eradication of Streptococcus pyogenes on the posterior pharyngeal wall and tonsils in 
the first two weeks after completion of antibiotic treatment and absence bacteriological 
recurrence beyond the 4-6-week period after completion of pharmacotherapy.
The economic analysis implied the calculation of the direct medical costs for 
antibacterial treatment. The cost of pharmacotherapy was determined based on the retail 
price of a child’s dosage form of the drug-brand.  As the drug-brands of oral penicillin, 
clarithromycin and azithromycin are not registered in Ukraine, the on-line resource 
Drugs.com was the drug price database of all studied antibiotics [10].
The pharmacoeconomic analysis was conducted from a patient-payer’s perspective. 
Horizon of modeling equals to duration course of acute streptococcal pharyngitis 
treatment.
Results and discussion.
Clinical evaluation. Quantitative assessment of clinical effect was measured 
with the odds ratio (OR) in the systematic review Cochrane [11]. Results of clinical 
trials indicated, that the risk of early bacteriological treatment failure was significantly 
reduced in the short duration treatment of clarithromycin (OR 0.22, 95% CI 0.12 to 
0.41), azithromycin (OR 0.33, 95% CI 0.14 to 0.76) and oral cefuroxime (OR 0.59, 95% 
CI 0.43 to 0.82) compared to recommended standard 10-day duration of oral penicillin 
[11]. Than the odds ratio was less the probability of early bacteriological treatment 
failure after short-term treatment lower.
There was no significant difference in the risk of late bacteriological recurrence 
between of short-duration antibiotics and recommended standard duration of oral 
penicillin [11]. Detailed estimation of clinical trials is presented in the Table 1.
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Table 1.
Clinical evaluation of short-term course chemotherapy  
of acute streptococcal pharyngitis in children
Interventions
Odds Ratio [M-H, Fixed, 95% CI]
SourceEarly bacteriological 
treatment failure
Late bacteriological 
recurrence
Penicillin V 13.3 mg/kg three times a day for 
10 days
versus 
Clarithromycin 7.5 mg/kg twice a day for 
5 days
0.22 [0.12, 0.41]* 1.08 [0.66, 1.75]** [8]
Penicillin V 15 mg/kg three times a day for 
10 days 
versus 
Azithromycin 20 mg/kg daily for 3 days
0.33 [0.14, 0.76]* 1.14 [0.55, 2.39]** [7]
Penicillin V 30 mg/kg three times a day for 
10 days 
versus 
Cefuroxime axetil 10 mg/kg (max 500 mg) 
twice a day for 5 days
0.59 [0.43, 0.82]* 0.81 [0.57, 1.14]** [9]
Penicillin V 30 mg/kg three times a day for 
10 days 
versus
Amoxicillin/clavulanate 43.8/6.2 mg/kg/day 
(max 1 g) twice a day for 5 days
0,94 [0.49, 1.84]** 0,70 [0.37, 1.32]** [15]
* Significant differences between groups, p <0.05
** No significant difference between groups, p> 0.05
Economic evaluation. Cost-minimization analysis showed that among pediatric 
dosage forms of studied antibiotics the 10-day oral penicillin in powder for oral solution 
had the lowest cost of course of treatment ($0.59 per 1 kg of a child’s body weight). Then 
clarithromycin ($2.96 per 1 kg), cefuroxime ($4.46 per 1 kg) and azithromycin ($6.74 
per 1 kg) were followed in order of cost increasing. 
However, considering the differences in clinical effectiveness of studied treatment 
approaches, direct comparison of the treatment cost does not answer the question of 
pharmacoeconomic value of antibiotics.
Economic evaluation of short-term course chemotherapy of acute streptococcal 
pharyngitis in children is presented in the Table 2.
123
Modern Science — Moderní věda 2017 № 2
Table 2
Economic assessment of short-term course chemotherapy 
 of acute streptococcal pharyngitis in children
INN Brand Names Cost,USD Regimen
The cost of 
treatment per 
1 kg, USD
Cost-
Effectivness 
Ratio per 1 
kg, USD
Phenoxymethyl 
penicillin
Penicillin V, powder 
for oral solution 
250 mg/5 mL, 200 mL, 
TEVA
19.77
10 mg/kg tid for 
10 days
13.3 mg/kg tid  
for 10 days
15 mg/kg tid for 
10 days
$0.59
$0.78
$0.88
$21.87
$30.35
$21.94
Clarithromycin
Biaxin, powder for 
oral suspension 
250 mg/5 mL, 50 mL, 
Abbvie
98.48 7.5 mg/kg bid for 5 days $2.96 $20.97
Cefuroxime 
axetil
Ceftin, powder for 
oral suspension 
250 mg/5 mL, 100 mL, 
GlaxoSmithKline
222.85
10 mg/kg (max 
500 mg) bid for 
5 days
$4.46 $20.40
Azithromycin
Zithromax, 200 mg/5 mL 
powder for oral 
suspension, 30 mL, 
Pfizer
134.71 20 mg/kg od for 3 days $6.74 $22.54
Amoxicillin/
clavulanic acid
Augmentin, powder 
for oral suspension 
250 mg/5 mL, 150 mL, 
GlaxoSmithKline
1260.7
43.8 mg/kg bid 
(max 1000 mg) 
for 5 days
40 mg/kg/day 
for 10 days
$36.81
$67.23
$74.64
-
The decision-tree model was constructed for the сost-effectiveness analysis of 
the acute streptococcal pharyngitis treatment depending on the probability of different 
outcomes [12].
Cost-effectiveness analysis of the 5-day course of clarithromycin and 10-day course 
of oral penicillin is presented on the Figure 1. Calculation results showed that the 
treatment cost of clarithromycin was in 3.8 times higher than the oral penicillin ($2.96/
kg versus $0.78/kg, respectively).
In cases early bacteriological treatment failure and late bacteriological recurrence, 
patients are prescribed amoxicillin/clavulanate (40 mg/kg/day) per 10 days for $67.23/
kg [13].
Considering lower likelihood of early bacteriological treatment failure of 
clarithromycin (5.6%) compared with oral penicillin (18.1%) and the no significant 
difference in the likelihood of late bacteriological recurrence after chemotherapy 
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of clarithromycin and oral penicillin, the financial cost of treating one patient with 
clarithromycin was:
0.056*($2.96+$67.23)+0.944*0.157*($2.96+$67.23)+0.944*0.843*$2.96=$3.93+
$10.4+$2.36=$16.69 per 1 kg of a child’s body weight.
The cost of treating one patient with oral penicillin was: 
0.181*($0.78+$67.23)+0.819*0.149*($0.78+$67.23)+0.819*0.851*$0.78=$12.31
+$8.30+$0.54=$21.15 per 1 kg of a child’s body weight.
Therefore, the financial cost of short-term therapy with clarithromycin was 26.7% 
less than the cost of standard therapy with oral penicillin.  
The cost-effectiveness ratio (CER) for clarithromycin was equaled 
$16.69/0.944*0.843=$20.97/kg per treatment success (cure without early 
bacteriological treatment failure and late bacteriological recurrence); for oral penicillin 
$21.15/0.819*0.851=$30.35/kg. Thus, the cost per unit of effectiveness of clarithromycin 
was 44.7% less than the cost per unit of effectiveness of oral penicillin.
Figure 1. The decision-tree model in pharmacoeconomic analysis of 5-day course of clarithromycin 
compared with 10-day course of oral penicillin in children with acute streptococcal pharyngitis
The next stage of our research was cost-effectiveness analysis of a 5-day course 
of oral cefuroxime and 10-day course of oral penicillin. As shown on the Figure 2, 
the financial costs for treating one patient with cefuroxime and oral penicillin hardly 
differed ($16.69/kg versus $16.65/kg, respectively). At the same time, the cost per unit 
of effectiveness of cefuroxime was 7.2% less than the cost per unit of effectiveness of 
oral penicillin that were equaled $20.40/kg and $22.66/kg, respectively.
The lower cost of the unit of effectiveness of cefuroxime is due to its clinically 
proven efficacy in the eradication of Streptococcus pyogenes. Cefuroxime reduces the 
probability of a repeated course of antibiotic chemotherapy with amoxicillin/clavulanate.
Seeing the relatively high retail price of cefuroxime, a wide range of its antimicrobial 
action and insignificant pharmacoeconomic benefits, cefuroxime should be considered 
as the drug of second-line therapy and used for the treatment of recurrent pharyngitis.
125
Modern Science — Moderní věda 2017 № 2
Figure 2. The decision-tree model in pharmacoeconomic analysis of 5-day course of oral cefuroxime 
compared with 10-day course of oral penicillin in children with acute streptococcal pharyngitis
The cost-effectiveness analysis of a 3-day course of azithromycin and 10-day course 
of oral penicillin (Figure 3) showed that the treatment of azithromycin was 10% more 
expensive than the treatment of oral penicillin ($18.57/kg versus $16.76/kg, respectively). 
The cost per unit of effectiveness (CER) of azithromycin was $22.54/kg, the CER of oral 
penicillin - $21.94/kg. Thus, the use of 3-day course of azithromycin is not economically 
expedient compared with oral penicillin.
Figure 3. The decision-tree model in pharmacoeconomic analysis of 3-day course of azithromycin 
compared with 10-day course of oral penicillin in children with acute streptococcal pharyngitis
According to expert assessment, which was conducted in our previous study, 
Ukrainian doctors had considered amoxicillin/clavulanate as the drug of choice for the 
treatment of acute streptococcal pharyngitis in children [14]. So, on the final stage of our 
research, we conducted the cost-effectiveness analysis of 5-day course of amoxicillin/
clavulanate compared with 10-day course of oral penicillin. 
The Figure 4 shows, that for one unit efficiency of amoxicillin/clavulanate it was 
necessary to spend 2.6 times more financial resources than for one unit efficiency of 
oral penicillin. The cost per unit of effectiveness (CER) of amoxicillin/clavulanate was 
$74.64/kg, the CER of oral penicillin – $29.10/kg.
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Moreover, there was no statistically significant clinical benefit in the eradication of 
Streptococcus pyogenes compared with standard therapy oral penicillin (Table. 1). The 
expenses for 5-day course of amoxicillin/clavulanate were 62.4 times higher than the 
expenses for 10-day course of oral penicillin ($36.81/kg versus $0.59/kg, respectively).
So, considering the lack of clinical benefits and high cost of treatment, amoxicillin/
clavulanate cannot be recommended as first-line drug for the treatment of acute 
streptococcal pharyngitis in children.
Figure 4. The decision-tree model in pharmacoeconomic analysis of 5-day course of amoxicillin/
clavulanate compared with 10-day course of oral penicillin in children with acute streptococcal 
pharyngitis
In order to determine the stability of the obtained results we conducted sensitivity 
analysis. Univariant sensitivity analysis of the cost-effectiveness ratio to fluctuations in 
the retail price of clarithromycin, cefuroxime and amoxicillin/clavulanate within ± 30% 
confirmed of the results stability. Pharmacoeconomic advantage of oral penicillin over 
azithromycin lost with 10% reduction in the retail prices.
Conclusions.
1. Direct comparison of the short-term and standard treatment cost showed that the 10-day 
oral penicillin in powder for oral solution was the lowest among pediatric dosage forms of 
all studied antibiotics. The cost of treatment was equaled to $0.59 per 1 kg of a child’s body 
weight. The 5-day course of clarithromycin ($ 2.96/kg) was the lowest among the short-term 
antibiotic courses.
2. Cost-effectiveness evaluation by using the decision-tree model demonstrated the cost-
effectiveness ratio (CER) of 5-day course of clarithromycin was 44.7% lower than CER of 
standard treatment with oral penicillin.
3. The 5-day course of clarithromycin is more expensive for the payer than 10-day course of 
oral penicillin, but it provides additional efficiency – lesser probability of early bacteriological 
treatment failure and the need to repeat an antibiotic therapy.
4. The use of 3-day course of azithromycin, 5-day courses of cefuroxime and amoxicillin/
clavulanate are pharmacoeconomic inexpedient compared with standard therapy.
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